Cargando…

Monoamine Oxidase A Hypomethylation in Obsessive-Compulsive Disorder: Reversibility By Successful Psychotherapy?

BACKGROUND: Epigenetic markers such as DNA methylation of the monoamine oxidase A (MAOA) gene have previously been shown to be altered in anxiety- and stress-related disorders and to constitute a potential mechanism of action of psychotherapeutic interventions such as cognitive behavioral therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiele, Miriam A, Thiel, Christiane, Deckert, Jürgen, Zaudig, Michael, Berberich, Götz, Domschke, Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251630/ https://www.ncbi.nlm.nih.gov/pubmed/32133483 http://dx.doi.org/10.1093/ijnp/pyaa016

Ejemplares similares

Epigenome-wide DNA methylation in obsessive-compulsive disorder
por: Schiele, Miriam A., et al.
Publicado: (2022)

DNA hypomethylation of the Krüppel-like factor 11 (KLF11) gene promoter: a putative biomarker of depression comorbidity in panic disorder and of non-anxious depression?
por: Kollert, Leonie, et al.
Publicado: (2020)

Interoceptive deficits in patients with obsessive-compulsive disorder in the time course of cognitive-behavioral therapy
por: Schultchen, Dana, et al.
Publicado: (2019)

MAOA gene hypomethylation in panic disorder—reversibility of an epigenetic risk pattern by psychotherapy
por: Ziegler, C, et al.
Publicado: (2016)

Obsessive-compulsive symptoms in two patients with strategic basal ganglia lesions
por: Endres, Dominique, et al.
Publicado: (2022)

Autoantibodies in patients with obsessive-compulsive disorder: a systematic review
por: Denzel, Dominik, et al.
Publicado: (2023)

Case Report: Possible autoimmune obsessive-compulsive disorder with postpartum onset
por: Endres, Dominique, et al.
Publicado: (2022)

The DNA methylome in panic disorder: a case-control and longitudinal psychotherapy-epigenetic study
por: Ziegler, Christiane, et al.
Publicado: (2019)

Homogeneous grey matter patterns in patients with obsessive-compulsive disorder
por: Koch, Kathrin, et al.
Publicado: (2021)

Obsessive–compulsive symptoms in ACTG1-associated Baraitser-Winter cerebrofrontofacial syndrome
por: Göbel, Theresa, et al.
Publicado: (2022)

Psychotherapy and medication management strategies for obsessive-compulsive disorder
por: Walsh, Kelda H, et al.
Publicado: (2011)

Impact of childhood maltreatment on obsessive-compulsive disorder symptom severity and treatment outcome
por: Boger, Sabrina, et al.
Publicado: (2020)

Functional and structural connectivity of the amygdala in obsessive-compulsive disorder
por: Rus, Oana Georgiana, et al.
Publicado: (2016)

Discontinuous Patterns of Brain Activation in the Psychotherapy Process of Obsessive-Compulsive Disorder: Converging Results from Repeated fMRI and Daily Self-Reports
por: Schiepek, Günter, et al.
Publicado: (2013)

Brief Dynamic Psychotherapy in a Case of Obsessive Compulsive Disorder
por: Vyjayanthi, S.
Publicado: (2014)

Dynamic Psychotherapy: The Therapeutic Process in the Treatment of Obsessive-Compulsive Disorder
por: Becker, Joana Proença, et al.
Publicado: (2019)

Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid
por: Endres, Dominique, et al.
Publicado: (2022)

Association between hippocampus volume and symptom profiles in obsessive–compulsive disorder
por: Reess, Tim Jonas, et al.
Publicado: (2017)

Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype?
por: Endres, Dominique, et al.
Publicado: (2022)

Deep clinical phenotyping of patients with obsessive-compulsive disorder: an approach towards detection of organic causes and first results
por: Runge, Kimon, et al.
Publicado: (2023)

Altered Cortico–Striatal Functional Connectivity During Resting State in Obsessive–Compulsive Disorder
por: Calzà, Jessica, et al.
Publicado: (2019)

Increased Default Mode Network Connectivity in Obsessive–Compulsive Disorder During Reward Processing
por: Koch, Kathrin, et al.
Publicado: (2018)

Examining Differences in Fear Learning in Patients With Obsessive-Compulsive Disorder With Pupillometry, Startle Electromyography and Skin Conductance Responses
por: Pöhlchen, Dorothee, et al.
Publicado: (2021)

Monoamine Oxidase A Gene Methylation and Its Role in Posttraumatic Stress Disorder: First Evidence from the South Eastern Europe (SEE)-PTSD Study
por: Ziegler, Christiane, et al.
Publicado: (2017)

Connectomics-based structural network alterations in obsessive-compulsive disorder
por: Reess, T J, et al.
Publicado: (2016)

Mindfulness-based psychotherapy in patients with obsessive-compulsive disorder: A meta-analytical Study
por: Riquelme-Marín, Antonio, et al.
Publicado: (2022)

2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors
por: Legoabe, Lesetja J, et al.
Publicado: (2015)

Genetics of obsessive-compulsive disorder
por: Mahjani, Behrang, et al.
Publicado: (2021)

Developmental aspects of fear: Comparing the acquisition and generalization of conditioned fear in children and adults
por: Schiele, Miriam A., et al.
Publicado: (2016)

Internet-based psychotherapy in children with obsessive-compulsive disorder (OCD): protocol of a randomized controlled trial
por: Conzelmann, Annette, et al.
Publicado: (2022)

Prevalence of Obsessive-Compulsive Spectrum Disorders in Obsessive-Compulsive Disorder
por: Siddiqui, Mohammad Aleem, et al.
Publicado: (2018)

Reducing Generalization of Conditioned Fear: Beneficial Impact of Fear Relevance and Feedback in Discrimination Training
por: Herzog, Katharina, et al.
Publicado: (2021)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)

Perceived Stress in Obsessive–Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms
por: Morgado, P., et al.
Publicado: (2013)

Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor
por: Zarmouh, Najla O., et al.
Publicado: (2016)

Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder
por: Yamamoto, Haruka, et al.
Publicado: (2012)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g8uvfltmkaihu5ugcfoka1i57b